{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:07:16Z","timestamp":1791090436756,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021831","name":"Institute of Microbiology, Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["311"],"award-info":[{"award-number":["311"]}],"id":[{"id":"10.13039\/501100021831","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373737"],"award-info":[{"award-number":["82373737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bioorg.2025.109132","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:03:09Z","timestamp":1761181389000},"page":"109132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Design, synthesis, and activity evaluation of novel tetrazole-based CYP51 inhibitors"],"prefix":"10.1016","volume":"166","author":[{"given":"Jiachen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maosheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109132_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/713687","article-title":"Antifungal resistance and new strategies to control fungal infections","volume":"2012","author":"Vandeputte","year":"2012","journal-title":"Int. J. Microbiol."},{"key":"10.1016\/j.bioorg.2025.109132_bb0010","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: Human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioorg.2025.109132_bb0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/14787210.2017.1328279","article-title":"Drug development challenges and strategies to address emerging and resistant fungal pathogens","volume":"15","author":"McCarthy","year":"2017","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.bioorg.2025.109132_bb0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/CMR.12.1.40","article-title":"Current and emerging azole antifungal agents","volume":"12","author":"Sheehan","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bioorg.2025.109132_bb0025","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1074\/jbc.M117.778308","article-title":"Structural analyses of candida albicans sterol 14\u03b1-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis","volume":"292","author":"Hargrove","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.109132_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113337","article-title":"Lead optimization generates selenium-containing miconazole CYP51 inhibitors with improved pharmacological profile for the treatment of fungal infections","volume":"216","author":"Xu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109132_bb0035","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1039\/D2TB02629E","article-title":"Cross-linkable star-hyperbranched unimolecular micelles for the enhancement of the anticancer activity of clotrimazole","volume":"11","author":"Gosecki","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioorg.2025.109132_bb0040","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.procbio.2023.10.024","article-title":"Triazole derivatives as potential antifungal agents: A structure-activity relationship (SAR) studies","volume":"135","author":"Hu","year":"2023","journal-title":"Process Biochem."},{"key":"10.1016\/j.bioorg.2025.109132_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13693786.2011.560197","article-title":"Overview of treatment options for invasive fungal infections","author":"Pound","year":"2011","journal-title":"Med. Mycol."},{"key":"10.1016\/j.bioorg.2025.109132_bb0050","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1093\/clinids\/12.Supplement_3.S276","article-title":"Fluconazole and other azoles: Translation of in vitro activity to in vivo and clinical efficacy","volume":"12","author":"Troke","year":"1990","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bioorg.2025.109132_bb0055","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1365-2230.2009.03698.x","article-title":"In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis: Activity of fluconazole, itraconazole, voriconazole and terbinafine against onychomycosis","volume":"35","author":"Bueno","year":"2009","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.bioorg.2025.109132_bb0060","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1128\/AAC.00163-06","article-title":"In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts","volume":"50","author":"Sabatelli","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2025.109132_bb0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijantimicag.2017.09.002","article-title":"The antifungal arsenal: Alternative drugs and future targets","volume":"51","author":"Wiederhold","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bioorg.2025.109132_bb0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejmech.2019.03.023","article-title":"Tetrazole hybrids and their antifungal activities","volume":"170","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109132_bb0075","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1016\/j.bmcl.2017.06.037","article-title":"Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors","volume":"27","author":"Yates","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109132_bb0080","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2217\/fmb-2021-0173","article-title":"Oteseconazole: An advance in treatment of recurrent vulvovaginal candidiasis","volume":"16","author":"Sobel","year":"2021","journal-title":"Future Microbiol."},{"key":"10.1016\/j.bioorg.2025.109132_bb0085","article-title":"In vitro activities of the novel investigational tetrazoles VT-1161 and VT-1598 compared to the triazole antifungals against azole-resistant strains and clinical isolates of candida albicans","volume":"63","author":"Nishimoto","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2025.109132_bb0090","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1016\/j.bmcl.2017.06.037","article-title":"Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors","volume":"27","author":"Yates","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109132_bb0095","doi-asserted-by":"crossref","unstructured":"A.T. Nishimoto, S.G. Whaley, N.P. Wiederhold, Q. Zhang, C.M. Yates, W.J. Hoekstra, R.J. Schotzinger, E.P. Garvey, P.D. Rogers, 1 63 (2019) e01304\u201319. Doi: https:\/\/doi.org\/10.1128\/AAC.01304-19.","DOI":"10.1128\/AAC.01304-19"},{"key":"10.1016\/j.bioorg.2025.109132_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116949","article-title":"Discovery of highly potent triazole derivatives with broad-spectrum antifungal activity based on iodiconazole","volume":"280","author":"Sun","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109132_bb0105","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1021\/jm051211n","article-title":"Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking","volume":"49","author":"Sheng","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109132_bb0110","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1016\/j.tetlet.2006.03.199","article-title":"Efficient microwave-assisted synthesis of 1-(1H-indol-1-yl)-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents","volume":"47","author":"Lebouvier","year":"2006","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2025.109132_bb0115","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1021\/acs.jmedchem.0c00102","article-title":"Discovery of novel fungal lanosterol 14\u03b1-demethylase (CYP51)\/histone deacetylase dual inhibitors to treat azole-resistant candidiasis","volume":"63","author":"Han","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109132_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116942","article-title":"Identification of novel and potent triazoles targeting CYP51 for antifungal: Design, synthesis, and biological study","volume":"280","author":"Sun","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109132_bb0125","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts","author":"CLSI","year":"2009"},{"key":"10.1016\/j.bioorg.2025.109132_bb0130","series-title":"Performance Standards for Antifungal Susceptibility Testing of Yeast","author":"CLSI","year":"2017"},{"key":"10.1016\/j.bioorg.2025.109132_bb0135","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1021\/acs.jmedchem.4c02305","article-title":"Lanosterol 14\u03b1-demethylase (CYP51)\/heat shock protein 90 (Hsp90) dual inhibitors for the treatment of invasive candidiasis","volume":"68","author":"Zhang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109132_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113740","article-title":"Design, synthesis and evaluation of novel 5-phenylthiophene derivatives as potent fungicidal of candida albicans and antifungal reagents of fluconazole-resistant fungi","volume":"225","author":"Yin","year":"2021","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825010120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825010120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:23:17Z","timestamp":1766064197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825010120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":28,"alternative-id":["S0045206825010120"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109132","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.6084\/m9.figshare.29992354.v1","asserted-by":"subject"},{"id-type":"uri","id":"https:\/\/drive.google.com\/file\/d\/1F1LWSJF_W3EsEkFCTODcaEAbjXAeT8mw\/view?usp=drivesdk","asserted-by":"subject"}]},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and activity evaluation of novel tetrazole-based CYP51 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109132"}}